| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Dec―28 |
Potential therapeutic intervention of melatonin against COVID-19: A comparative pharmacokinetic study |
AKASH ACHARYYA, KAZI NURUL HASAN |
| 2 |
[GO] |
2024―Apr―25 |
Melatonin and viral infections: A review focusing on therapeutic effects and SARS-CoV-2 |
Leonor Chacin-Bonilla, Ernesto Bonilla |
| 3 |
[GO] |
2023―Dec―31 |
Melatonin and Covid-19: An opened Pandora's box and the hope for the time being |
Leonor Chacin-Bonilla, Ernesto Bonilla |
| 4 |
[GO] |
2023―Sep―29 |
The preventive and protective role of melatonin in SARS-CoV-2 infection: a retrospective study |
Antonio Molina-Carballo, Antonio Emilio Jerez-Calero, Luisa Fernández-López, María del Carmen Augustin-Morales, Antonio Muñoz-Hoyos, Ahmad Agil |
| 5 |
[GO] |
2022―Oct―03 |
A geographical approach to the development of hypotheses relating to Covid-19 death rates |
Margaret Skutsch, Roger D. Seheult, Jaime Loya |
| 6 |
[GO] |
2021―Dec―20 |
Melatonin reduces the mortality of severely-infected COVID-19 patients |
Dun-Xian Tan, Russel J Reiter |
| 7 |
[GO] |
2021―Oct―11 |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
Russel J Reiter, Daniel P Cardinali, Richard L Neel, Alberto Dominguez Rodriguez, Gregory M D Brown, Jan Tesarik |
| 8 |
[GO] |
2021―Apr―30 |
Does the melatonin supplementation decrease the severity of the outcomes in COVID-19 patients? A mini review of observational data in the in vivo and in vitro studies |
Mohammad Gholizadeh, Faezeh Abaj, Hossein Hasani, Atieh Mirzababaei, Khadijeh Mirzaei |
| 9 |
[GO] |
2021―Jan―04 |
Melatonin: A potential therapeutic agent against COVID-19 |
Sangiliyandi Gurunathan, Min-Hee Kang, Youngsok Choi, Russel J Reiter, Jin-Hoi Kim |
| 10 |
[GO] |
2021―Jan―04 |
Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation |
Luis I. Brusco, Pablo Cruz, Alicia V Cangas, Carmen González Rojas, Daniel E Vigo, Daniel Pedro Cardinali |
| 11 |
[GO] |
2021―Jan―04 |
Melatonin-Index as a biomarker for predicting the distribution of presymptomatic and asymptomatic SARS-CoV-2 carriers |
Pedro A Fernandes, Gabriela S Kinker, Bruno V Navarro, Vinicius C Jardim, Edson D Ribeiro-Paz, Marlina O Córdoba-Moreno, et al. (+7) Débora Santos-Silva, Sandra M Muxel, André Fujita, Carolina Borsoi Moraes, Helder I Nakaya, Marcos S Buckeridge, Regina P Markus |
| 12 |
[GO] |
2021―Jan―04 |
An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination |
Daniel P Cardinali, Gregory M Brown, Seithikurippu R Pandi-Perumal |
| 13 |
[GO] |
2020―Oct―09 |
Avoiding room light during night may stimulate immunity in COVID-19 patients by promoting melatonin production |
Murtada Ahmed Ahmed |
| 14 |
[GO] |
2020―Oct―09 |
Low melatonin as a contributor to SARS-CoV-2 disease |
Seithikurippu R Pandi-Perumal, Daniel P Cardinali, Russel J Reiter, Gregory M Brown |
| 15 |
[GO] |
2020―Oct―09 |
Melatonin attenuates growth factor receptor signaling required for SARS-CoV-2 replication |
Jan Tesarik |
| 16 |
[GO] |
2020―Jun―15 |
Estimated doses of melatonin for treating deadly virus infections: focus on COVID-19 |
Dun-Xian Tan, Rüdiger Hardeland |
| 17 |
[GO] |
2020―Jun―15 |
Protection by melatonin in respiratory diseases: valuable information for the treatment of COVID-19 |
Ruediger Hardeland, Dun-Xian Tan |
| 18 |
[GO] |
2020―Jun―15 |
Melatonin as a potential therapeutic molecule against COVID-19 associated gastrointestinal complications: An unrevealed link |
Palash Kumar Pal, Aindrila Chattopadhyay, Debasish Bandyopadhyay |
| 19 |
[GO] |
2020―Jun―15 |
Plasticity of glucose metabolism in activated immune cells: advantages for melatonin inhibition of COVID-19 disease |
Russel J Reiter, Ramaswamy Sharma, Qiang Ma, Changwei Liu, Walter Manucha, Pedro Abreu-Gonzalez, Alberto Dominguez-Rodriguez |
| 20 |
[GO] |
2020―Jun―15 |
High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection |
Daniel Pedro Cardinali |
| 21 |
[GO] |
2020―Jun―15 |
COVID-19 pathophysiology: interactions of gut microbiome, melatonin, vitamin D, stress, kynurenine and the alpha 7 nicotinic receptor: Treatment implications |
George Anderson, Russel J Reiter |
| 22 |
[GO] |
2020―Jun―15 |
Melatonin, cardiovascular disease and COVID-19: A potential therapeutic strategy? |
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Paul E Marik, Russel J Reiter |
| 23 |
[GO] |
2020―Jun―15 |
Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series |
Rafael Ricafranca Castillo, Gino Rei A. Quizon, Mario Joselito M. Juco, Arthur Dessi E. Roman, Donnah G De Leon, Felix Eduardo R. Punzalan, et al. (+4) Rafael Bien L. Guingon, Dante D. Morales, Dun-Xian Tan, Russe J Reiter |
| 24 |
[GO] |
2020―Jun―15 |
The potential of melatonin in the prevention and attenuation of oxidative hemolysis and myocardial injury from cd147 SARS-CoV-2 spike protein receptor binding |
Doris Loh |
| 25 |
[GO] |
2020―Jun―15 |
ER stress and autophagy induced by SARS-CoV-2: The targets for melatonin treatment |
Jose Antonio Boga, Ana Coto-Montes |
| 26 |
[GO] |
2020―Mar―23 |
Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on COVID-19 |
Dunxian X Tan, Ruegiger Hardeland |
